Author： Ho Lap Qin Weiping Stetka Breton S. Pasinetti Giulio M.
Publisher： Adis International
ISSN： 1172-7047
Source： CNS Drugs, Vol.20, Iss.2, 2006-01, pp. : 85-98
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Do Selective Cyclo-Oxygenase-2 Inhibitors Have a Future?
Drug Safety, Vol. 28, Iss. 3, 2005-01 ,pp. :
Access to resources
Recommend
Angiogenesis inhibitors may be effective in Alzheimer's disease?
Inpharma, Vol. 1, Iss. 1375, 2003-01 ,pp. :
Cyclo-Oxygenase-2 Inhibitors: Rationale and Therapeutic Potential for Alzheimers Disease
By McGeer P.L.
Drugs & Aging, Vol. 17, Iss. 1, 2000-07 ,pp. :
Cyclo-Oxygenase-2 Inhibitors: When Should They Be Used in the Elderly?
By Savage Ruth
Drugs & Aging, Vol. 22, Iss. 3, 2005-01 ,pp. :
Selective Cyclo-Oxygenase-2 Inhibitors and Myocardial Infarction: How Strong is the Link?
By Howes L.G.
Drug Safety, Vol. 25, Iss. 12, 2002-01 ,pp. :